Advanced in WT1-Related Wilms Tumor Syndromes

Dr. Jonathan A. Chatzkel

Hematology Oncology | Hematology | Oncology
University of Florida Health
Florida Clinical Practice Association Inc
2000 Sw Archer Rd, Uf Health Congenital Heart, 
Gainesville, FL 
Accepting New Patients
Offers Telehealth

Advanced in WT1-Related Wilms Tumor Syndromes
University of Florida Health
Florida Clinical Practice Association Inc
2000 Sw Archer Rd, Uf Health Congenital Heart, 
Gainesville, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jonathan Chatzkel is a Hematologist Oncology specialist and a Hematologist in Gainesville, Florida. Dr. Chatzkel is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Prostate Cancer, Familial Prostate Cancer, Nephrectomy, and Orchiectomy. Dr. Chatzkel is currently accepting new patients.

His clinical research consists of co-authoring 17 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in FL
Hospital Affiliations
Uf Health Shands Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Florida Blue
  • EPO
  • PPO
Freedom Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

FLORIDA CLINICAL PRACTICE ASSOCIATION INC
2000 Sw Archer Rd, Uf Health Congenital Heart, Gainesville, FL 32610
Call: 352-265-8250
Other Locations
FLORIDA CLINICAL PRACTICE ASSOCIATION INC
2001 Sw 13th St, Gi Clinic At Endoscopy Cen, Gainesville, FL 32608
Call: 352-265-8982
FLORIDA CLINICAL PRACTICE ASSOCIATION INC
1600 Sw Archer Rd, Suite 100371, Gainesville, FL 32610

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


5 Clinical Trials

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Enrollment Status: Suspended
Publish Date: October 15, 2025
Intervention Type: Drug
Study Drugs: Atezolizumab, Tivozanib
Study Phase: Phase 1/Phase 2
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Enrollment Status: Active_not_recruiting
Publish Date: October 09, 2025
Intervention Type: Other, Biological, Procedure
Study Drug: Pembrolizumab
Study Phase: Phase 3
PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]
PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Other, Procedure, Drug, Biological
Study Drugs: Cabozantinib, Ipilimumab, Nivolumab
Study Phase: Phase 3
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)
Enrollment Status: Active_not_recruiting
Publish Date: September 11, 2025
Intervention Type: Drug, Procedure, Other, Radiation
Study Drugs: Abiraterone acetate, Apalutamide, Bicalutamide, Buserelin, Degarelix, Flutamide, Goserelin, Histrelin, Leuprolide, Prednisone, Triptorelin
Study Phase: Phase 3
A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
Enrollment Status: Active_not_recruiting
Publish Date: July 28, 2025
Intervention Type: Other, Biological, Procedure
Study Drug: Nivolumab
Study Phase: Phase 3
View 4 Less Clinical Trials

17 Total Publications

Near-complete resolution of tumour thrombus in a patient with advanced non-seminomatous germ cell tumour: a multidisciplinary approach without surgical intervention.
Near-complete resolution of tumour thrombus in a patient with advanced non-seminomatous germ cell tumour: a multidisciplinary approach without surgical intervention.
Journal: BMJ case reports
Published: July 05, 2025
View All 17 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Safeer A. Ashraf
Hematology Oncology | Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Safeer A. Ashraf
Hematology Oncology | Hematology | Oncology

Cancer Specialists LLC

14546 Old Saint Augustine Rd, 
Jacksonville, FL 
 (59.8 miles away)
904-260-9445
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Safeer Ashraf is a Hematologist Oncology specialist and a Hematologist in Jacksonville, Florida. Dr. Ashraf is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Paget Disease of the Breast, Inflammatory Breast Cancer, Pulmonary Embolism, and Angiosarcoma. Dr. Ashraf is currently accepting new patients.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. John H. Vu
Oncology | Hematology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. John H. Vu
Oncology | Hematology

Baptist MD Anderson Cancer Physicians Inc

14546 Old Saint Augustine Rd, Suite 105, 
Jacksonville, FL 
 (59.8 miles away)
904-202-7300
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

John Vu is an Oncologist and a Hematologist in Jacksonville, Florida. Dr. Vu is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and EGFR Positive Lung Cancer. Dr. Vu is currently accepting new patients.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Andrew M. Weber
Hematology | Hematology Oncology | Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Andrew M. Weber
Hematology | Hematology Oncology | Oncology

Ocala Oncology Center Pl

3130 Sw 32nd Ave, 
Ocala, FL 
 (34.9 miles away)
352-732-4032
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Andrew Weber is a Hematologist and a Hematologist Oncology provider in Ocala, Florida. Dr. Weber is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Paget Disease of the Breast, Pleuropulmonary Blastoma, Lung Cancer, and Febrile Neutropenia. Dr. Weber is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Chatzkel's expertise for a condition
ConditionClose
      • Advanced
      • Adult Soft Tissue Sarcoma
        Dr. Chatzkel is
        Advanced
        . Learn about Adult Soft Tissue Sarcoma.
        See more Adult Soft Tissue Sarcoma experts
      • Chromophobe Renal Cell Carcinoma
        Dr. Chatzkel is
        Advanced
        . Learn about Chromophobe Renal Cell Carcinoma.
        See more Chromophobe Renal Cell Carcinoma experts
      • Clear Cell Sarcoma
        Dr. Chatzkel is
        Advanced
        . Learn about Clear Cell Sarcoma.
        See more Clear Cell Sarcoma experts
      • Familial Prostate Cancer
        Dr. Chatzkel is
        Advanced
        . Learn about Familial Prostate Cancer.
        See more Familial Prostate Cancer experts
      • Familial Wilms Tumor 2
        Dr. Chatzkel is
        Advanced
        . Learn about Familial Wilms Tumor 2.
        See more Familial Wilms Tumor 2 experts
      • Prostate Cancer
        Dr. Chatzkel is
        Advanced
        . Learn about Prostate Cancer.
        See more Prostate Cancer experts
      View All 9 Advanced Conditions
      • Experienced
      • Adrenal Cancer
        Dr. Chatzkel is
        Experienced
        . Learn about Adrenal Cancer.
        See more Adrenal Cancer experts
      • Bladder Cancer
        Dr. Chatzkel is
        Experienced
        . Learn about Bladder Cancer.
        See more Bladder Cancer experts
      • Head and Neck Squamous Cell Carcinoma (HNSCC)
        Dr. Chatzkel is
        Experienced
        . Learn about Head and Neck Squamous Cell Carcinoma (HNSCC).
        See more Head and Neck Squamous Cell Carcinoma (HNSCC) experts
      • Hereditary Neuroblastoma
        Dr. Chatzkel is
        Experienced
        . Learn about Hereditary Neuroblastoma.
        See more Hereditary Neuroblastoma experts
      • Metastatic Brain Tumor
        Dr. Chatzkel is
        Experienced
        . Learn about Metastatic Brain Tumor.
        See more Metastatic Brain Tumor experts
      • Muscle Invasive Bladder Cancer
        Dr. Chatzkel is
        Experienced
        . Learn about Muscle Invasive Bladder Cancer.
        See more Muscle Invasive Bladder Cancer experts
      View All 15 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2025 All Rights Reserved